Literature DB >> 18851930

Advanced electrocardiographic predictors of mortality in familial dysautonomia.

I Solaimanzadeh1, T T Schlegel, A H Feiveson, E C Greco, J L DePalma, V Starc, H Marthol, M Tutaj, S Buechner, F B Axelrod, M J Hilz.   

Abstract

OBJECTIVE: To identify electrocardiographic predictors of mortality in patients with familial dysautonomia (FD).
METHODS: Ten-minute resting high-fidelity 12-lead electrocardiograms (ECGs) were obtained from 14 FD patients and 14 age/gender-matched healthy subjects. Multiple conventional and advanced ECG parameters were studied for their ability to predict mortality over a subsequent 4.5-year period, including representative parameters of heart rate variability (HRV), QT variability (QTV), T-wave complexity, signal averaged ECG, and 3-dimensional ECG.
RESULTS: Four of the 14 FD patients died during the follow-up period, three with concomitant pulmonary disorder. Of the ECG parameters studied, increased non-HRV-correlated QTV and decreased HRV were the most predictive of death. Compared to controls as a group, FD patients also had significantly increased ECG voltages, JTc intervals and waveform complexity, suggestive of structural heart disease.
CONCLUSION: Increased QTV and decreased HRV are markers for increased risk of death in FD patients. When present, both markers may reflect concurrent pathological processes, especially hypoxia due to pulmonary disorders and sleep apnea.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18851930     DOI: 10.1016/j.autneu.2008.08.016

Source DB:  PubMed          Journal:  Auton Neurosci        ISSN: 1566-0702            Impact factor:   3.145


  7 in total

1.  Sudden Unexpected Death During Sleep in Familial Dysautonomia: A Case-Control Study.

Authors:  Jose-Alberto Palma; Lucy Norcliffe-Kaufmann; Miguel A Perez; Christy L Spalink; Horacio Kaufmann
Journal:  Sleep       Date:  2017-08-01       Impact factor: 5.849

2.  Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction.

Authors:  Todd T Schlegel; Walter B Kulecz; Alan H Feiveson; E Carl Greco; Jude L DePalma; Vito Starc; Bojan Vrtovec; M Atiar Rahman; Michael W Bungo; Matthew J Hayat; Terry Bauch; Reynolds Delgado; Stafford G Warren; Tulio Núñez-Medina; Rubén Medina; Diego Jugo; Håkan Arheden; Olle Pahlm
Journal:  BMC Cardiovasc Disord       Date:  2010-06-16       Impact factor: 2.298

3.  Beat-to-beat QT interval dynamics and variability in familial dysautonomia.

Authors:  Udi Nussinovitch; Uriel Katz; Moshe Nussinovitch; Naomi Nussinovitch
Journal:  Pediatr Cardiol       Date:  2009-11-14       Impact factor: 1.655

4.  QT interval variability in body surface ECG: measurement, physiological basis, and clinical value: position statement and consensus guidance endorsed by the European Heart Rhythm Association jointly with the ESC Working Group on Cardiac Cellular Electrophysiology.

Authors:  Mathias Baumert; Alberto Porta; Marc A Vos; Marek Malik; Jean-Philippe Couderc; Pablo Laguna; Gianfranco Piccirillo; Godfrey L Smith; Larisa G Tereshchenko; Paul G A Volders
Journal:  Europace       Date:  2016-01-27       Impact factor: 5.214

5.  Evidence of cardiac electrical remodeling in patients with Huntington disease.

Authors:  Ksenija Cankar; Ziva Melik; Jan Kobal; Vito Starc
Journal:  Brain Behav       Date:  2018-07-20       Impact factor: 2.708

Review 6.  Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options.

Authors:  Péter Bencsik; Kamilla Gömöri; Tamara Szabados; Péter Sántha; Zsuzsanna Helyes; Gábor Jancsó; Péter Ferdinandy; Anikó Görbe
Journal:  Br J Pharmacol       Date:  2020-03-21       Impact factor: 8.739

7.  Conventional QT variability measurement vs. template matching techniques: comparison of performance using simulated and real ECG.

Authors:  Mathias Baumert; Vito Starc; Alberto Porta
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.